vs
Idexx Laboratories(IDXX)とウィン・リゾーツ(WYNN)の財務データ比較。上の社名をクリックして会社を切り替えられます
ウィン・リゾーツの直近四半期売上が大きい($1.9B vs $1.1B、Idexx Laboratoriesの約1.7倍)。Idexx Laboratoriesの純利益率が高く(22.8% vs 5.4%、差は17.4%)。Idexx Laboratoriesの前年同期比売上増加率が高い(14.3% vs 1.5%)。Idexx Laboratoriesの直近四半期フリーキャッシュフローが多い($326.3M vs $306.8M)。過去8四半期でIdexx Laboratoriesの売上複合成長率が高い(6.4% vs 0.1%)
IDEXXラボラトリーズは1983年設立の米国多国籍企業で、伴侶動物獣医療、家畜・家禽、水質検査、乳製品分野向けの製品・サービスの開発・製造・流通を手がけています。本社はメイン州ウェストブルックにあり、EMEA地域の拠点はオランダのホーフドルプに置かれています。
ウィン・リゾーツはネバダ州パラダイスに本社を置く米国の上場企業で、高級ホテルとカジノの開発・運営を主力事業としている。2002年に元ミラージュリゾーツ会長兼CEOのスティーブ・ウィンにより設立され、現在のCEOはクレイグ・ビリングスで、2020年時点で計6施設を開発している。
IDXX vs WYNN — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | ||
|---|---|---|
| 売上 | $1.1B | $1.9B |
| 純利益 | $248.2M | $100.0M |
| 粗利率 | 60.3% | — |
| 営業利益率 | 28.9% | 14.7% |
| 純利益率 | 22.8% | 5.4% |
| 売上前年比 | 14.3% | 1.5% |
| 純利益前年比 | 14.8% | -63.9% |
| EPS(希薄化後) | $3.09 | $0.96 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $1.1B | $1.9B | ||
| Q3 25 | $1.1B | $1.8B | ||
| Q2 25 | $1.1B | $1.7B | ||
| Q1 25 | $998.4M | $1.7B | ||
| Q4 24 | $954.3M | $1.8B | ||
| Q3 24 | $975.5M | $1.7B | ||
| Q2 24 | $1.0B | $1.7B | ||
| Q1 24 | $964.1M | $1.9B |
| Q4 25 | $248.2M | $100.0M | ||
| Q3 25 | $274.6M | $88.3M | ||
| Q2 25 | $294.0M | $66.2M | ||
| Q1 25 | $242.7M | $72.7M | ||
| Q4 24 | $216.1M | $277.0M | ||
| Q3 24 | $232.8M | $-32.1M | ||
| Q2 24 | $203.3M | $111.9M | ||
| Q1 24 | $235.6M | $144.2M |
| Q4 25 | 60.3% | — | ||
| Q3 25 | 61.8% | — | ||
| Q2 25 | 62.6% | — | ||
| Q1 25 | 62.4% | — | ||
| Q4 24 | 59.8% | — | ||
| Q3 24 | 61.1% | — | ||
| Q2 24 | 61.7% | — | ||
| Q1 24 | 61.5% | — |
| Q4 25 | 28.9% | 14.7% | ||
| Q3 25 | 32.1% | 16.9% | ||
| Q2 25 | 33.6% | 15.2% | ||
| Q1 25 | 31.7% | 15.8% | ||
| Q4 24 | 27.4% | 20.0% | ||
| Q3 24 | 31.2% | 7.9% | ||
| Q2 24 | 26.3% | 15.6% | ||
| Q1 24 | 31.0% | 19.5% |
| Q4 25 | 22.8% | 5.4% | ||
| Q3 25 | 24.8% | 4.8% | ||
| Q2 25 | 26.5% | 3.8% | ||
| Q1 25 | 24.3% | 4.3% | ||
| Q4 24 | 22.7% | 15.1% | ||
| Q3 24 | 23.9% | -1.9% | ||
| Q2 24 | 20.3% | 6.5% | ||
| Q1 24 | 24.4% | 7.7% |
| Q4 25 | $3.09 | $0.96 | ||
| Q3 25 | $3.40 | $0.85 | ||
| Q2 25 | $3.63 | $0.64 | ||
| Q1 25 | $2.96 | $0.69 | ||
| Q4 24 | $2.62 | $2.43 | ||
| Q3 24 | $2.80 | $-0.29 | ||
| Q2 24 | $2.44 | $0.91 | ||
| Q1 24 | $2.81 | $1.30 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | ||
|---|---|---|
| 現金・短期投資手元流動性 | $180.1M | $1.5B |
| 総負債低いほど良い | $450.0M | $10.5B |
| 株主資本純資産 | $1.6B | $-275.5M |
| 総資産 | $3.4B | $13.1B |
| 負債/資本比率低いほどレバレッジが低い | 0.28× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $180.1M | $1.5B | ||
| Q3 25 | $208.2M | $1.5B | ||
| Q2 25 | $164.6M | $2.0B | ||
| Q1 25 | $164.0M | $2.1B | ||
| Q4 24 | $288.3M | $2.4B | ||
| Q3 24 | $308.6M | $2.4B | ||
| Q2 24 | $401.6M | $2.4B | ||
| Q1 24 | $397.4M | $2.4B |
| Q4 25 | $450.0M | $10.5B | ||
| Q3 25 | — | $10.6B | ||
| Q2 25 | — | $10.5B | ||
| Q1 25 | — | $10.6B | ||
| Q4 24 | $617.8M | $10.5B | ||
| Q3 24 | — | $11.8B | ||
| Q2 24 | — | $11.0B | ||
| Q1 24 | — | $11.2B |
| Q4 25 | $1.6B | $-275.5M | ||
| Q3 25 | $1.6B | $-370.0M | ||
| Q2 25 | $1.5B | $-441.5M | ||
| Q1 25 | $1.4B | $-360.7M | ||
| Q4 24 | $1.6B | $-224.2M | ||
| Q3 24 | $1.6B | $-281.4M | ||
| Q2 24 | $1.6B | $-109.8M | ||
| Q1 24 | $1.6B | $-137.0M |
| Q4 25 | $3.4B | $13.1B | ||
| Q3 25 | $3.4B | $12.8B | ||
| Q2 25 | $3.3B | $12.7B | ||
| Q1 25 | $3.2B | $12.7B | ||
| Q4 24 | $3.3B | $13.0B | ||
| Q3 24 | $3.4B | $14.1B | ||
| Q2 24 | $3.4B | $13.3B | ||
| Q1 24 | $3.4B | $13.5B |
| Q4 25 | 0.28× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.39× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | ||
|---|---|---|
| 営業キャッシュフロー直近四半期 | $355.8M | $478.0M |
| フリーキャッシュフロー営業CF - 設備投資 | $326.3M | $306.8M |
| FCFマージンFCF / 売上 | 29.9% | 16.4% |
| 設備投資強度設備投資 / 売上 | 2.7% | 9.2% |
| キャッシュ転換率営業CF / 純利益 | 1.43× | 4.78× |
| 直近12ヶ月FCF直近4四半期 | $1.1B | $692.2M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $355.8M | $478.0M | ||
| Q3 25 | $402.3M | $335.8M | ||
| Q2 25 | $185.7M | $405.1M | ||
| Q1 25 | $238.0M | $133.8M | ||
| Q4 24 | $262.0M | $479.0M | ||
| Q3 24 | $220.1M | $279.3M | ||
| Q2 24 | $248.3M | $352.8M | ||
| Q1 24 | $198.6M | $315.1M |
| Q4 25 | $326.3M | $306.8M | ||
| Q3 25 | $371.2M | $171.8M | ||
| Q2 25 | $151.6M | $239.8M | ||
| Q1 25 | $207.9M | $-26.2M | ||
| Q4 24 | $232.8M | $351.8M | ||
| Q3 24 | $192.0M | $178.0M | ||
| Q2 24 | $215.0M | $259.1M | ||
| Q1 24 | $168.3M | $217.4M |
| Q4 25 | 29.9% | 16.4% | ||
| Q3 25 | 33.6% | 9.4% | ||
| Q2 25 | 13.7% | 13.8% | ||
| Q1 25 | 20.8% | -1.5% | ||
| Q4 24 | 24.4% | 19.1% | ||
| Q3 24 | 19.7% | 10.5% | ||
| Q2 24 | 21.4% | 15.0% | ||
| Q1 24 | 17.5% | 11.7% |
| Q4 25 | 2.7% | 9.2% | ||
| Q3 25 | 2.8% | 8.9% | ||
| Q2 25 | 3.1% | 9.5% | ||
| Q1 25 | 3.0% | 9.4% | ||
| Q4 24 | 3.1% | 6.9% | ||
| Q3 24 | 2.9% | 6.0% | ||
| Q2 24 | 3.3% | 5.4% | ||
| Q1 24 | 3.1% | 5.2% |
| Q4 25 | 1.43× | 4.78× | ||
| Q3 25 | 1.47× | 3.80× | ||
| Q2 25 | 0.63× | 6.12× | ||
| Q1 25 | 0.98× | 1.84× | ||
| Q4 24 | 1.21× | 1.73× | ||
| Q3 24 | 0.95× | — | ||
| Q2 24 | 1.22× | 3.15× | ||
| Q1 24 | 0.84× | 2.18× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
IDXX
| Vet Lab Consumables | $389.0M | 36% |
| Reference Laboratory Diagnostic And Consulting Services | $349.2M | 32% |
| Rapid Assay Products | $76.0M | 7% |
| Recurring Revenue | $70.6M | 6% |
| CAG Diagnostic Capital Instruments | $58.1M | 5% |
| Water Segment | $50.5M | 5% |
| Livestock And Poultry Diagnostics Segment | $37.5M | 3% |
| CAG Diagnostics Service And Accessories | $35.3M | 3% |
| Systems And Hardware | $20.1M | 2% |
| Rebate And Up Front Considerations Arrangements | $2.4M | 0% |
| Extended Warranties And Post Contract Support Revenue | $1.0M | 0% |
WYNN
| Casino | $1.1B | 61% |
| Occupancy | $305.1M | 16% |
| Food And Beverage | $264.9M | 14% |
| Entertainment Retail And Other | $152.6M | 8% |